Obese adipose tissue is markedly infiltrated by macrophages, suggesting that they may participate in the inflammatory pathways that are activated in obese adipose tissue. Evidence has suggested that saturated fatty acids released via adipocyte lipolysis serve as a naturally occurring ligand that stimulates Toll-like receptor (TLR)4 signaling, thereby inducing the inflammatory responses in macrophages in obese adipose tissue. Through a combination of cDNA microarray analyses of saturated fatty acid-stimulated macrophages in vitro and obese adipose tissue in vivo, here we identified activating transcription factor (ATF)3, a member of the ATF/cAMP response element-binding protein family of basic leucine zipper-type transcription factors, as a target gene of saturated fatty acids/TLR4 signaling in macrophages in obese adipose tissue. Importantly, ATF3, when induced by saturated fatty acids, can transcriptionally repress tumor necrosis factor-␣ production in macrophages in vitro. Chromatin immunoprecipitation assay revealed that ATF3 is recruited to the region containing the activator protein-1 site of the endogenous tumor necrosis factor-␣ promoter. Furthermore, transgenic overexpression of ATF3 specifically in macrophages results in the marked attenuation of proinflammatory M1 macrophage activation in the adipose tissue from genetically obese KKA y mice fed high-fat diet. This study provides evidence that ATF3, which is induced in obese adipose tissue, acts as a transcriptional repressor of saturated fatty acids/TLR4 signaling, thereby revealing the negative feedback mechanism that attenuates obesity-induced macrophage activation. Our data also suggest that activation of ATF3 in macrophages offers a novel therapeutic strategy to prevent or treat obesity-induced adipose tissue inflammation. (Circ Res. 2009;105:25-32.) 
established risk factors for cardiovascular disease (visceral fat obesity, impaired glucose metabolism, atherogenic dyslipidemia, and blood pressure elevation), is an increasing health problem worldwide. [1] [2] [3] The pathophysiology underlying the metabolic syndrome is not fully understood and visceral fat obesity appears to be an important component. 4 There is considerable evidence that obesity is a state of chronic low-grade inflammation, which may play a critical role in the pathophysiology of the metabolic syndrome. [1] [2] [3] Obese adipose tissue is markedly infiltrated by macrophages, suggesting that they may participate in the inflammatory pathways that are activated in obese adipose tissue. 5 Using an in vitro coculture system composed of adipocytes and macrophages, we have provided evidence that a paracrine loop involving saturated fatty acids and tumor necrosis factor (TNF)␣ derived from adipocytes and macrophages, respectively, establishes a vicious cycle that augment the inflammatory change in obese adipose tissue. 6 Recent studies have also pointed to the heterogeneity of macrophages infiltrated into obese adipose tissue, ie, they follow 2 different polarization states: M1, or "classically activated" (proinflammatory) macrophages, which are induced by proinflammatory mediators such as lipopolysaccharide (LPS) and Th1 cytokine interferon-␥; and M2, or "alternatively activated" (antiinflammatory) macrophages, which are generated in vitro by expo-sure to Th2 cytokines such as interleukin (IL)-4 and IL-13. [7] [8] [9] Evidence has accumulated indicating that macrophages, which are infiltrated into obese adipose tissue, exhibit the phenotypic change from M2 to M1 polarization. [7] [8] [9] Recent evidence also showed that the nuclear receptor peroxisome proliferator-activated receptor-␥ or -␦ regulates M2 polarization of adipose tissue macrophages and thus systemic insulin sensitivity. 8, 9 It is, therefore, conceivable that M1 macrophages induce the release of saturated fatty acids from hypertrophied adipocytes via lipolysis, which, in turn, may serve as a proinflammatory adipocytokine locally in the adipose tissue.
Free fatty acids represent an important energy source mobilized from triglycerides stored in the adipose tissue, particularly during periods of starvation, but recent evidence has suggested the pathophysiologic roles other than the supply of nutrients in times of fasting or increased energy demand. 10 For instance, elevated levels of circulating free fatty acids, which are often associated with visceral fat obesity, increase fat accumulation in insulin target tissues such as the skeletal muscle and liver and contribute to insulin resistance. 11 We and others have reported that saturated fatty acids, which are released from adipocytes via the macrophage-induced lipolysis, serve as a naturally occurring ligand for Toll-like receptor (TLR)4 complex, which is essential for the recognition of LPS, to induce nuclear factor (NF)-B activation in macrophages. [12] [13] [14] Evidence has also suggested that TLR4 plays an important role in adipose tissue inflammation. 14 -17 Because macrophages in obese adipose tissue are exposed to saturated fatty acids released in large quantities from hypertrophied adipocytes, there might be negative regulatory mechanisms, whereby macrophages are protected against the saturated fatty acid-induced inflammatory response in obese adipose tissue.
Through a combination of cDNA microarray analyses of saturated fatty acid-stimulated macrophages in vitro and obese adipose tissue in vivo, we identified activating transcription factor (ATF)3, a member of the ATF/cAMP response element-binding protein (CREB) family of basic leucine zipper-type transcription factors 18, 19 that is markedly induced in macrophages through TLR4 in response to saturated fatty acids in vitro and in obese adipose tissue in vivo. This study provides evidence that ATF3 acts as a transcriptional repressor of saturated fatty acids/TLR4 signaling in macrophages, thereby revealing the negative feedback mechanism that attenuates obesity-induced macrophage activation in obese adipose tissue. Our data also suggest that activation of ATF3 in macrophages offers a novel therapeutic strategy to prevent or treat obesity-induced inflammation and thus the metabolic syndrome associated with excess adiposity.
Materials and Methods
An expanded Materials and Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Materials and Antibodies
Details are provided in the Online Data Supplement.
Animals
Six-week-old male C3H/HeJ mice, which have defective LPS signaling attributable to a missense mutation in the TLR4 gene, 20 and control C3H/HeN mice were purchased from CLEA Japan (Tokyo, Japan). Genetically obese ob/ob, db/db, and KKA y mice were purchased from CLEA Japan and Charles River Japan (Tokyo, Japan). Details on experimental conditions are provided in the Online Data Supplement. All animal experiments were conducted in accordance to the guidelines of Tokyo Medical and Dental University Committee on Animal Research (No. 0090058).
Generation of Transgenic Mice Overexpressing ATF3 in Macrophages
Cell Culture
RAW264 macrophage cell line (RIKEN BioResource Center, Tsukuba, Japan), 3T3-L1 preadipocytes, and HEK293 (American Type Culture Collection, Manassas, Va) were maintained in DMEM (Nacalai Tesque, Kyoto, Japan) containing 10% FBS (BioWest, Miami, Fla). Differentiation of 3T3-L1 preadipocytes to mature adipocytes was performed as previously described 6, 12 and used as differentiated 3T3-L1 adipocytes at days 8 to 10 after the induction of differentiation. Murine peritoneal macrophages and bone marrow-derived macrophages were prepared as described. 12
Chromatin Immunoprecipitation Assay
Retrovirus-Mediated Overexpression and Knockdown of ATF3 in Macrophages
Retrovirus-mediated overexpression of the full-length mouse ATF3 cDNA and knockdown of endogenous ATF3 were performed in RAW264 macrophages as described in the Online Data Supplement.
Quantitative Real-Time PCR
Total RNA was extracted from cultured cells using Sepazol reagent (Nacalai Tesque) and quantitative real-time PCR was performed with an ABI Prism 7000 Sequence Detection System using PCR Master Mix Reagent (Applied Biosystems, Foster City, Calif). 6, 12 Primers used in this study are described in Online Table I . Levels of mRNA were normalized to those of 36B4 mRNA.
Histological Analysis
Histological analysis was performed as previously described using the paraffin-embedded sections of the epididymal white adipose tissue. 15 In brief, hematoxylin/eosin staining was used to compare the adipocyte cell size with the software Win Roof (Mitani, Chiba, Japan). 15 The presence of F4/80-positive macrophages in the adipose tissue was detected immunohistochemically using the rat monoclonal antimouse F4/80 antibody 21 as described previously. 15 The number of F4/80-positive cells was counted in more than 10 mm 2 area of each section and expressed as the mean number/mm 2 .
Western Blotting of ATF3
Whole cell lysates were prepared as previously described. 6 Samples (20 g protein per lane) were separated by 12.5% SDS-PAGE and Western blotting was performed using antibodies against ATF3 (Santa Cruz Biotechnology).
Measurement of TNF␣ Levels in Culture Media
The TNF␣ levels in culture supernatants were determined by a commercially available ELISA kit (R&D systems, Minneapolis, Minn). 6
Transient Transfection and Luciferase Assay
Data were expressed as the meansϮSE. Statistical analysis was performed using ANOVA, followed by Scheffe's test unless otherwise described. PϽ0.05 was considered to be statistically significant.
Results and Discussion

Identification of ATF3 As a Target Gene of Saturated Fatty Acids in Macrophages in Obese Adipose Tissue
We have provided in vitro evidence that saturated fatty acids, which are released from adipocytes via the macrophageinduced lipolysis, serves as a naturally occurring ligand that stimulates TLR4 signaling in macrophages. 12 To search for target gene(s) of saturated fatty acids in macrophages in obese adipose tissue, we performed cDNA microarray analysis of obese adipose tissue from ob/ob mice and palmitatestimulated RAW264 macrophages (Online Figure I, a) . Upregulated genes under both conditions included chemokines, proinflammatory cytokines, acute phase reactants, and ATF3 (Online Table II ), whereas 5 genes were downregulated (Online Table III ). ATF3 is a member of the ATF/CREB family of transcription factors. 18, 19 ATF3 is rapidly induced in response to several stimuli and insults, such as chemicals, irradiation, and oxidative stress, and, in turn, negatively regulates target genes as a transcriptional repressor. 18, 19 Although ATF3 plays a role in apoptosis and cell cycle, 18, 19, 22 the role of ATF3 in obesity is largely unknown. We, therefore, investigated the tissue distribution of ATF3 in obese and lean mice. Similar to macrophage marker F4/80, ATF3 mRNA expression was markedly increased in the adipose tissue from db/db mice relative to wild-type mice (Online Figure I, b ). In this study, there was a significant increase in ATF3 mRNA expression in the liver from db/db mice relative to wild-type mice (PϽ0.01).
We confirmed our cDNA microarray data by real-time PCR and immunostaining. Expression of ATF3 and F4/80 mRNAs was increased in the adipose tissue during the course of diet-induced obesity ( Figure 1A ). We also observed upregulation of ATF3 and F4/80 in the adipose tissue from ob/ob mice ( Figure 1B ). Collagenase digestion of the adipose tissue, which is validated by F4/80 and adiponectin mRNA expression, revealed that ATF3 is expressed predominantly in stromal-vascular fraction in the adipose tissue ( Figure 1C ). Furthermore, ATF3 mRNA expression was increased significantly in ob/ob mice fed high-fat diet relative to wild-type mice fed standard diet (PϽ0.01) ( Figure 1C ). We also confirmed by immunostaining of ATF3 and F4/80 using serial sections of obese adipose tissue that most ATF3positive cells are stained with F4/80 ( Figure 1D ). These observations indicate that ATF3 is markedly upregulated in obese adipose tissue, especially in infiltrated macrophages.
Saturated Fatty Acids Induce ATF3 via TLR4 in Macrophages In Vitro and In Vivo
We next examined the involvement of TLR4 in the saturated fatty acid-induced ATF3 mRNA and protein expression in macrophages in vitro. Saturated fatty acids, such as palmitate and stearate, and LPS increased significantly ATF3 mRNA and protein expression in RAW264 macrophages (PϽ0.05 versus vehicle) (Figure 2A through 2D) . Interestingly, unsaturated fatty acids, such as oleate and eicosapentaenoic acid, did not affect ATF3 mRNA expression ( Figure 2C and 2D and data not shown), suggesting the structure-specific effect of free fatty acids. We found that palmitate fails to increase ATF3 mRNA expression in peritoneal macrophages from C3H/HeJ mice with defective TLR4 signaling ( Figure 2E ). We also observed that BAY11-7085, an NF-B inhibitor, markedly inhibits the palmitate-induced ATF3 mRNA expression in RAW264 macrophages ( Figure 2F ). The data were confirmed using RAW264 macrophages overexpressing a super-repressor form of IB␣ (SR-IB␣) ( Figure 2G ). Furthermore, selective NF-B activation by transient overexpression of p50 and p65 subunits of NF-B increased significantly the ATF3 promoter activity in HEK293 cells (PϽ0.01) ( Figure 2H ). In this setting, the changes in ATF3 mRNA expression were almost parallel to those in TNF␣ mRNA expression ( Figure 2E and 2F and data not shown). These observations indicate that TLR4/NF-B pathway plays an important role in saturated fatty acid-induced ATF3 and TNF␣ expression in macrophages. On the other hand, palmitate and stearate, but not unsaturated fatty acids, are known to serve as precursors for de novo ceramide synthesis, thereby inducing inflammatory changes in certain cells. 23, 24 However, we observed that pharmacological inhibition of ceramide synthesis slightly inhibits the palmitate-induced ATF3 mRNA expression in RAW264 macrophages (T. Suganami, I. Shirakawa, Y. Ogawa, unpublished data, 2009). These observations, taken together, suggest that saturated fatty acid-induced ATF3 expression is mediated mostly through the TLR4/NF-B pathway.
We next examined the role of TLR4 in ATF3 expression in the interaction between adipocytes and macrophages. We have established an in vitro coculture system composed of adipocytes and macrophages and found that saturated fatty acids, which are released from adipocytes via the macro-phage-induced lipolysis, are capable of activating the TLR4/ NF-B signaling. 6, 12 Coculture of 3T3-L1 adipocytes with peritoneal macrophages from C3H/HeN mice resulted in the upregulation of ATF3 and TNF␣ mRNAs, which was significantly inhibited in the coculture with peritoneal macrophages from C3H/HeJ mice (PϽ0.05) (Online Figure II, a) . We found that BAY11-7085 effectively inhibits the upregulation of ATF3 and TNF␣ mRNA expression in the coculture system (Online Figure II, b) .
Using C3H/HeJ and C3H/HeN mice fed high-fat diet, we also examined the involvement of TLR4 in obesity-induced ATF3 expression in the adipose tissue. There were no significant differences in body weight and adipose tissue weight between high-fat diet-fed C3H/HeN and C3H/HeJ mice (Online Table IV ). Similar to our previous data on TNF␣, 15 the high-fat diet-induced increase in ATF3 mRNA expression was significantly attenuated in the adipose tissue from C3H/HeJ mice relative to C3H/HeN mice (PϽ0.01) ( Figure 3A ). Importantly, there was no significant change in the number of macrophages infiltrated into the adipose tissue, as assessed by F4/80 immunostaining ( Figure 3B ), suggesting the attenuation of macrophage activation in C3H/HeJ mice. Immunohistochemical analysis also confirmed the marked reduction of ATF3 staining in C3H/HeJ mice relative to C3H/HeN mice during the high-fat diet ( Figure 3C ). Collectively, these observations suggest that the saturated fatty acid-induced ATF3 expression in macrophages is mediated via TLR4 in vitro and in vivo.
ATF3 Reduces Saturated Fatty Acid-Induced TNF␣ Production in Macrophages
To elucidate the functional role of ATF3 in macrophages, we examined the effect of ATF3 overexpression on proinflammatory cytokine production in macrophages in vitro. A full-length mouse ATF3 cDNA was stably overexpressed in RAW264 macrophages by retroviral transduction, which was confirmed by real-time PCR and Western blotting ( Figure  4A ). In RAW264 macrophages overexpressing ATF3 (ATF3-RAW264), the palmitate-and LPS-induced increase in TNF␣ mRNA expression was significantly reduced relative to control RAW264 macrophages (Mock-RAW264) (PϽ0.01) (Figure 4B ). We confirmed that the palmitate-and LPS-induced increase in TNF␣ secretion in the ATF3-RAW264 culture media is significantly reduced relative to Mock-RAW264 (PϽ0.01) ( Figure 4C ). We also observed with a luciferase reporter assay that TNF␣ promoter activity is markedly inhibited in ATF3-RAW264 relative to Mock-RAW264 (Figure 4D) . Similarly, the palmitate-induced increase in IL-6 and inducible nitric oxide synthase was significantly reduced in ATF3-RAW264 relative to Mock-RAW264 (Online Figure  III, a) . These observations indicate that overexpression of ATF3 is capable of reducing the saturated fatty acid-induced proinflammatory cytokine production in macrophages.
We next examined the effect of knockdown of endogenous ATF3 gene expression in RAW264 macrophages. Stable knockdown of ATF3 using 2 independent short hairpin loop RNAs (shATF3#1 and shATF3#3) was confirmed by Western blotting (Figure 5A ). The ATF3-knocked-down RAW264 macrophages (shATF3#1-RAW264 and shATF3#3-RAW264) exhibited significant enhancement of the palmitate-induced TNF␣ mRNA expression relative to control RAW264 macrophages (shGFP-RAW264) (PϽ0.01) ( Figure 5B ). The effect of ATF3 knockdown on TNF␣ mRNA expression persisted until 24 hours after stimulation with LPS ( Figure  5C ). Knockdown of ATF3 also significantly increased TNF␣ secretion in the culture media (PϽ0.01) ( Figure 5D ). Furthermore, we observed that the TNF␣ promoter activity is significantly increased in shATF3#3-RAW264 relative to shGFP-RAW264 (PϽ0.01) ( Figure 5E ). These observations suggest that once induced by the saturated fatty acids/TLR4 signaling, ATF3 attenuates the saturated fatty acid-induced TNF␣ production in macrophages, thereby constitute a negative feedback mechanism to reduce the TLR4 signaling induction of proinflammatory cytokine production. This notion is consistent with a recent report by Gilchrist et al that ATF3 acts as a negative regulator of the LPS-induced TLR4 signaling. 25 In the proximal region of the IL-6 and IL-12b promoters, ATF3-binding ATF/CREB sites are located close to NF-B binding sites. 25 NF-B and ATF3, both of which are activated by saturated fatty acids/TLR4 signaling, can positively and negatively regulate their target proinflammatory cytokines, respectively. 25 However, there are no consensus sequences corresponding to the ATF/CREB site close to the NF-Bbinding site (Ϫ534 bp) in the proximal region of TNF␣ promoter. In this study, we performed chromatin immunoprecipitation analysis with RAW264 macrophages and found that ATF3 is recruited to the region containing the activator protein (AP)-1 site (Ϫ926 bp) of the endogenous TNF␣ promoter ( Figure 5F ). This observation is consistent with a previous report that ATF3 binds to the AP-1 site. 26 It is, therefore, interesting to know how ATF3 negatively regulates TNF␣ and IL-6 production via its distinct binding sites; the AP-1 and ATF/CREB sites, respectively. In addition, histone deacetylase and heat shock transcription factor 1 are required for the action of ATF3 on the IL-6 promoter. 25, 27 It is, therefore, important to identify ATF3-interacting proteins on the TNF␣ promoter.
Distinct Intracellular Signaling Pathways Plays a Role in the Palmitate-and LPS-Induced ATF3 Expression
In this study, we demonstrated that saturated fatty acids induce ATF3 expression in macrophages through the TLR4/ NF-B pathway, which is consistent with the previous report on LPS. 25 Besides NF-B, mitogen-activated protein kinases (MAPKs) are an important intracellular signaling pathway downstream of TLR4, 28 and c-Jun N-terminal kinase (JNK) and p38 MAPK have been reported to play a role in ATF3 expression in certain cell types. 29, 30 We, therefore, examined the involvement of MAPKs in the saturated fatty acid-and LPS-induced ATF3 mRNA expression and found that SB20358038, a p38 MAPK inhibitor, inhibits significantly the palmitate-induced ATF3 mRNA expression (PϽ0.01) (Online Figure IV) . On the other hand, SP600125, a JNK inhibitor, inhibited most effectively the LPS-induced ATF3 mRNA expression (PϽ0.01) (Online Figure IV) . Moreover, we found that ERK plays a major role in the palmitateinduced TNF␣ mRNA expression, whereas other MAPKs may also contribute to the LPS-induced TNF␣ mRNA expression (Online Figure IV) . These observations, taken together, suggest that distinct intracellular signaling pathways may mediate the saturated fatty acid-and LPS-induced ATF3 mRNA expression through TLR4. It is interesting to know how endogenous and exogenous TLR4 ligands such as saturated fatty acids, oxidized phospholipids, and cytosolic and nuclear proteins, and LPS, 12, 28, 31 exert their effects through the unique signaling pathways, thereby leading to a variety of cellular responses.
Transgenic Overexpression of ATF3 Attenuates Macrophage Activation in Obese Adipose Tissue
To elucidate the role of ATF3 in macrophages infiltrated into obese adipose tissue, we developed transgenic mice overexpressing human ATF3 in macrophages under the control of SR-A promoter (ATF3 Tg) (Online Figure V, a) . 32 Genomic Southern blot analysis identified 9 (line 2), 13 (line 25), and 20 (line 35) transgene copies in independent founder lines (data not shown). Western blot analysis of ATF3 revealed 3-fold and 2-fold increase in ATF3 protein levels in bone marrow-derived macrophages from lines 25 and 35, respectively, relative to wild-type mice (Online Figure V, b) . In this study, there was no significant increase in ATF3 levels in line 2 macrophages (Online Figure V, b) . We observed essentially the same data using peritoneal macrophages from 3 independent transgenic lines (Online Figure V, b) .
We crossed ATF3 Tg (line 35) with genetically obese KKA y mice and obtained 4 genotypes as the F1 generation (wild-type on the KK background [WT:KK], ATF3 Tg on the KK background [ATF3 Tg:KK], wild-type on the KKA y background [WT:KKA y ], and ATF3 Tg on the KKA y background [ATF3 Tg:KKA y ]) at a Mendelian ratio (data not shown). In this study, WT:KK and ATF3 Tg:KK were fed standard diet and WT:KKA y and ATF3 Tg:KKA y were fed high-fat diet for 4 weeks. During the course of high-fat diet feeding, transgenic overexpression of ATF3 in macrophages did not affect significantly body weight and epididymal fat weight on KK and KKA y backgrounds ( Figure 6A and 6B) . The liver weight tended to be decreased in ATF3 Tg:KKA y relative to WT:KKA y , but the difference did not reach statistical significance ( Figure 6B ). Histological analysis showed no apparent difference in adipocyte cell size between genotypes ( Figure 6C and 6D ). There was no significant difference in obesity-induced macrophage infiltration be- tween WT:KKA y and ATF3 Tg:KKA y (Figure 6E and 6F) . These observations suggest that transgenic overexpression of ATF3 in macrophages does not affect adipocyte hypertrophy and macrophage infiltration in obese adipose tissue.
We also examined the effect of ATF3 on macrophage activation and polarization in the adipose tissue from transgenic mice with macrophage-specific overexpression of ATF3. We observed a marked increase in TNF␣ mRNA expression in the adipose tissue from WT:KKA y relative to WT:KK, which was significantly attenuated in ATF3 Tg:KKA y (PϽ0.05) ( Figure 7A ). In this study, M1 macrophage marker CD11c was also increased in the adipose tissue from WT:KKA y relative to WT:KK ( Figure 7B ), which was effectively inhibited in ATF3 Tg:KKA y (PϽ0.05) ( Figure  7A ). Moreover, IL-6 mRNA expression tended to be decreased in the adipose tissue from ATF3 Tg:KKA y mice relative to WT:KKA y (Online Figure III, b) . By contrast, we found no significant difference in mRNA expression of M2 macrophage markers, mannose receptor and arginase 1, among genotypes ( Figure 7B ). These observations suggest that overexpression of ATF3 in macrophages is capable of inhibiting macrophage activation and M1 polarization in the adipose tissue in vivo (Figure 8 ).
We next examined TNF␣ and CD11c mRNA expression in peritoneal macrophages prepared from ATF3 Tg and WT on the C57BL/6J background. Similar to the data on the adipose tissue ( Figure 7A ), TNF␣ mRNA expression was significantly suppressed in peritoneal macrophages from ATF3 Tg relative to WT (PϽ0.05) ( Figure 7C ). Interestingly, CD11c mRNA expression in peritoneal macrophages was rather higher in ATF3 Tg than in WT (PϽ0.05) ( Figure 7C ). In this regard, using ATF3-RAW264 and shATF3-RAW264, we did not observe that ATF3 has impact on CD11c mRNA expression in vitro (data not shown), suggesting that CD11c may not be a transcriptional target of ATF3 in macrophages. Further studies are needed to elucidate the role of ATF3 in obesityinduced M1 polarization of adipose tissue macrophages. Global ATF3-deficient mice are viable, 19, 25 but the role of ATF3 in glucose/lipid metabolism has not been elucidated. Because activation and polarization of adipose tissue macrophages play an important role in the metabolic status, 7-9 studies with ATF3 Tg and macrophage-specific ATF3deficient mice would help elucidate the pathophysiologic role of ATF3 in macrophages in adipose tissue inflammation and systemic glucose/lipid metabolism.
In conclusion, ATF3 is upregulated in macrophages in the interaction between adipocytes and macrophages through the saturated fatty acids/TLR4/NF-B signaling. Once induced, ATF3 can transcriptionally reduce the saturated fatty acids/ TLR4 signaling induction of proinflammatory cytokine production. Among known negative regulators of TLR4 signaling, 28 ATF3 is unique in that it represses the TLR4 target genes via a transcriptional mechanism. This study provides evidence that ATF3 acts as a transcriptional repressor of saturated fatty acids/TLR4 signaling, thereby revealing the negative feedback mechanism that attenuates macrophage activation in obese adipose tissue (Figure 8 ). Our data also suggest that activation of ATF3 in macrophages may offer a novel therapeutic strategy to prevent or treat obesity-induced adipose tissue inflammation. Negative feedback mechanism involving ATF3 as a transcriptional repressor of saturated fatty acid/TLR4 signaling in macrophages in obese adipose tissue. In the interaction between adipocytes and macrophages, ATF3 is upregulated in macrophages through the saturated fatty acids/TLR4/NF-B signaling. Once induced, ATF3 can transcriptionally reduce the saturated fatty acids/TLR4 signaling-induced proinflammatory cytokine production. Our data have identified ATF3 as a transcriptional repressor of saturated fatty acid/TLR4 signaling, thereby revealing the negative feedback mechanism that attenuates macrophage activation in obese adipose tissue. TNFR indicates TNF␣ receptor; AP-1 and B, AP-1-and NF-B-binding elements, respectively.
